For the next thirty days, ThinkGenetic is offering a chance for our champions and advocates to support the project on Kickstarter! That’s right, for as little as $25 you can… CONTINUE
Frequently Asked Question: Will the Site Contain Information in Other Languages than English?
As we spread the news about ThinkGenetic we come across those who have questions about this exciting project. Especially questions around how individuals, groups, organizations and advocates can get involved!… CONTINUE
Frequently Asked Questions: How Can Parents Be Involved?
As we spread the news about ThinkGenetic we love to chat with the community and answer any questions about our exciting site. As these questions come in we like to share… CONTINUE
ThinkGenetic Founder, Dawn Laney, to be honored at 2016 Rare Impact Awards on May 17th
Coming this May, NORD is hosting the 2016 Rare Impact Awards to bring together the rare disease community and to honor and celebrate outstanding achievements. During the event NORD will recognize the… CONTINUE
Protected: UK-Based PolyPeople Joins ThinkGenetic in Raising Awareness of Rare Cancers
There is no excerpt because this is a protected post.
ThinkGenetic Accepted into 5th Annual M2D2 100K Challenge
ThinkGenetic, Inc., has been accepted to present at the second round of The University of Massachusetts’ Medical Device Development Center (M2D2), 5th Annual M2D2 100K Challenge on Wednesday, March 23,… CONTINUE
Ready for Life Science Fast Track 2016 by The Capital Network?
Co-Founders Dave Jacob and Len Barker will be attending the Life Sciences Fast Track 2016 on Thursday, February 25, 2016 from 9:00 AM to 4:30 PM at the Nutter McClennen &… CONTINUE
Video: Why ThinkGenetic is the Best New Innovation in Pediatric Healthcare
ThinkGenetic is a labor of love between ThinkGenetic, Inc., Emory University’s Department of Human Genetics and IBM. Supported by International Advocacy groups like The Legacy of Angels, NORD and Genetic… CONTINUE
ThinkGenetic to Exhibit with Emory Genetics Laboratory at WORLDSymposium™
ThinkGenetic, Inc., is proud to be exhibiting alongside Emory Genetics Laboratory at the Manchester Grand Hyatt San Diego the week of February 29 – March 4, 2016 to demonstrate the beta of ThinkGenetic. This… CONTINUE
ThinkGenetic Accepted to Participate in Boston’s M2D2 “Barracuda Bowl”
ThinkGenetic, Inc., is excited to announce it has been selected to pitch at the upcoming M2D2 “Barracuda Bowl” on January 27, 2016 at Mintz Levin in Boston,MA. The “Barracuda Bowl” is a… CONTINUE
Boston Globe Article: “Wrong or late diagnosis likely to affect most Americans”
In the article “Wrong or late diagnosis likely to affect most Americans” from September 23rd, Lena H. Sun touches on some key information uncovered in an report from the Institute of… CONTINUE
IBM and ThinkGenetic Sign Commercial Agreement to Use Watson
After a rigorous review of the ThinkGenetic business plan, IBM signed a commercial agreement allowing the use of Watson in the ThinkGenetic product. Using expertise in information science, library science… CONTINUE
A Historic Partnership: ThinkGenetic and Emory University School of Medicine
ThinkGenetic was created by a consortium of organizations driven by the desire to improve the lives of those living with a genetic disease. Our story begins with ThinkGenetic, Inc. co-founder, Dave… CONTINUE
- « Previous Page
- 1
- …
- 5
- 6
- 7